SCHEMBL12792049

SCHEMBL12792049

O=P(c1ccccc1)(c1ccccc1)n1c2ccccc2c2cc3c(cc21)c1ccccc1n3P(=O)(c1ccccc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 3/20 0.40
▸ KDM4E B2RXH2 3/20 0.37
▸ ATM Q13315 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ CA2 P00918 1/20 0.34
▸ CA4 P22748 1/20 0.34
▸ CA5A P35218 1/20 0.34
▸ GPR3 P46089 1/20 0.34
▸ POLB P06746 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ FABP3 P05413 2/20 0.33
▸ FABP4 P15090 2/20 0.33
▸ FABP5 Q01469 2/20 0.33
▸ USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23431347 0.92 NPSR1 (0.44) NPSR1KDM4EATML3MBTL1ALDH1A1
SCHEMBL12792102 0.89 KDM4E (0.53) NPSR1KDM4EATML3MBTL1ALDH1A1
SCHEMBL16447094 0.85 NPSR1 (0.42) NPSR1KDM4EATML3MBTL1ALDH1A1
SCHEMBL23911727 0.84 KDM4E (0.46) NPSR1KDM4EATML3MBTL1ALDH1A1
SCHEMBL12792062 0.81 NPSR1 (0.40) NPSR1KDM4EATML3MBTL1ALDH1A1
SCHEMBL28889116 0.79 NR4A2 (0.41) —
SCHEMBL28400807 0.78 MEN1 (0.33) NPSR1POLBMEN1MAPTMAPK1
SCHEMBL28401361 0.78 MAPT (0.46) NPSR1KDM4EL3MBTL1ALDH1A1GPR3
SCHEMBL17449861 0.77 KIF11 (0.44) NPSR1L3MBTL1ALDH1A1MEN1MAPK1
SCHEMBL30122564 0.76 NPSR1 (0.44) NPSR1KDM4EATML3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2293357-B1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL & SUMIKIN CHEM CO (JP) 2014-12-10 — — EP disclosed
US-20110057184-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL CO., LTD. (JP) 2011-03-10 — — US disclosed
US-20110057184-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL CO., LTD. (JP) 2011-03-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110057184-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE LAS1L, EML4, OXA1L NPSR1 4771/4885KDM4E 2598/4885ATM 2091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback